Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.
Leukocyte trafficking from peripheral blood into affected tissues is an essential component of the inflammatory reaction to virtually all forms of injury and is an important factor in the development of many kidney diseases. Advances in the past few years have highlighted the central role of a family of chemotactic cytokines called chemokines in this process. Chemokines help to control the selective migration and activation of inflammatory cells into injured renal tissue. Chemokines and their receptors are expressed by intrinsic renal cells as well as by infiltrating cells during renal inflammation. This study summarizes the in vitro and in vivo data on chemokines and chemokine receptors in renal diseases with a special focus on potential therapeutic effects on inflammatory processes.
Segerer
Stephan
S
Medizinische Poliklinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Munich, Germany.
Nelson
Peter J
PJ
Medizinische Poliklinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Munich, Germany.
Schlöndorff
Detlef
D
Medizinische Poliklinik, Klinikum Innenstadt der Ludwig-Maximilians-Universität, Munich, Germany.
D000208:Acute Disease; D000818:Animals; D018925:Chemokines / Q000145:classification / Q000502:physiology*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D007674:Kidney Diseases / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D019707:Receptors, Chemokine / Q000502:physiology*; D012680:Sensitivity and Specificity
D018925:Chemokines; D019707:Receptors, Chemokine